Entry |
|
Name |
Efferocytosis - Bufo gargarizans (Asiatic toad) |
Class |
Cellular Processes; Transport and catabolism
|
Pathway map |
|
Organism |
Bufo gargarizans (Asiatic toad) [GN: bgar]
|
Gene |
122943763 | LOW QUALITY PROTEIN: phospholipid-transporting ATPase ABCA1-like [KO:K05641] |
122940814 | NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332] |
122937923 | LOW QUALITY PROTEIN: nuclear factor of activated T-cells, cytoplasmic 1-like [KO:K04446] |
122945175 | nuclear factor of activated T-cells, cytoplasmic 1-like isoform X1 [KO:K04446] |
122920397 | NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333] |
122923932 | NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 isoform X1 [KO:K17334] |
122923213 | ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097] |
122943713 | PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530] |
122944170 | peroxisome proliferator-activated receptor gamma-like [KO:K08530] |
122944434 | CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870] |
122946366 | transforming growth factor beta-1 proprotein-like isoform X1 [KO:K13375] |
122946419 | transforming growth factor beta-1 proprotein-like isoform X1 [KO:K13375] |
122943504 | CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17] |
122939966 | CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17] |
122927375 | CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17] |
122938621 | ADGRB1; adhesion G protein-coupled receptor B1 isoform X1 [KO:K04596] |
122928325 | T-cell immunoglobulin and mucin domain-containing protein 4-like [KO:K20413] |
122920389 | BCAR1; breast cancer anti-estrogen resistance protein 1 [KO:K05726] |
122938214 | ELMO1; engulfment and cell motility protein 1 isoform X1 [KO:K12366] |
122944424 | ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392] |
122944817 | ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392] |
122942311 | disintegrin and metalloproteinase domain-containing protein 9-like isoform X1 [KO:K06834] [EC:3.4.24.-] |
122925669 | disintegrin and metalloproteinase domain-containing protein 9-like [KO:K06834] [EC:3.4.24.-] |
122927318 | ADAM9; disintegrin and metalloproteinase domain-containing protein 9 [KO:K06834] [EC:3.4.24.-] |
122930508 | LRP1; prolow-density lipoprotein receptor-related protein 1 [KO:K04550] |
122935265 | MEGF10; multiple epidermal growth factor-like domains protein 10 [KO:K24068] |
122929545 | MEGF11; multiple epidermal growth factor-like domains protein 11 [KO:K24068] |
122932520 | SCARF1; scavenger receptor class F member 1 isoform X1 [KO:K24318] |
122944407 | GULP1; PTB domain-containing engulfment adapter protein 1 isoform X1 [KO:K23285] |
122932361 | TGFBRAP1; transforming growth factor-beta receptor-associated protein 1 [KO:K20177] |
122923145 | vacuolar protein sorting-associated protein 8 homolog [KO:K20178] |
122944991 | VPS8; vacuolar protein sorting-associated protein 8 homolog [KO:K20178] |
122934937 | VPS11; vacuolar protein sorting-associated protein 11 homolog [KO:K20179] |
122944401 | VPS16; vacuolar protein sorting-associated protein 16 homolog isoform X1 [KO:K20180] |
122921987 | VPS18; vacuolar protein sorting-associated protein 18 homolog [KO:K20181] |
122924531 | VPS33A; vacuolar protein sorting-associated protein 33A [KO:K20182] |
122938470 | VPS41; vacuolar protein sorting-associated protein 41 homolog [KO:K20184] |
122943293 | PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355] |
122926331 | SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299] |
122940685 | PECAM1; platelet endothelial cell adhesion molecule isoform X1 [KO:K06471] |
|
Compound |
C00019 | S-Adenosyl-L-methionine |
C04230 | 1-Acyl-sn-glycero-3-phosphocholine |
C06124 | Sphingosine 1-phosphate |
C15610 | Cholest-5-ene-3beta,26-diol |
|
Reference |
|
Authors |
Doran AC, Yurdagul A Jr, Tabas I |
Title |
Efferocytosis in health and disease. |
Journal |
|
Reference |
|
Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
Journal |
|
Reference |
|
Authors |
Kawano M, Nagata S |
Title |
Efferocytosis and autoimmune disease. |
Journal |
|
Reference |
|
Authors |
Mehrotra P, Ravichandran KS |
Title |
Drugging the efferocytosis process: concepts and opportunities. |
Journal |
|
Reference |
|
Authors |
Park SY, Kim IS |
Title |
Engulfment signals and the phagocytic machinery for apoptotic cell clearance. |
Journal |
|
Reference |
|
Authors |
Kojima Y, Weissman IL, Leeper NJ |
Title |
The Role of Efferocytosis in Atherosclerosis. |
Journal |
|
Related pathway |
|
KO pathway |
|
LinkDB |
|